U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation for SEP-363856, a novel…
Drug-Trial News
The U.S. Food and Drug Administration today announced the agency is requiring a new boxed…
US FDA Approves Brexanolone (ZULRESSO) -First Treatment for Post-Partum Depression The U.S. Food and Drug…
The U.S. Food and Drug Administration has approved Spravato (esketamine) nasal spray, in conjunction with…
Gelesis, a biotechnology company developing first-in-class hydrogel therapeutics to treat obesity and other chronic diseases…
